Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

West Haven, Connecticut 06516


Purpose:

This clinical trial compares a combination of two drugs that constrict blood vessels (Sandostatin LAR and Midodrine) to albumin after large volume paracentesis. Subjects have cirrhosis and ascites.


Study summary:

This prospective, placebo-controlled, randomized, clinical trial compares the effect of a combination of vasoconstrictors (octreotide plus midodrine) to albumin on the time to recurrence of ascites in patients with refractory ascites treated with large volume paracentesis. The treatment allocation ratio for the two treatment arms is 1:1 using a stratified random permuted block design. Subjects are patients 18-80 years old with cirrhosis and ascites who are stratified according to the presence or absence of renal dysfunction at the time of randomization. Measurements include blood pressure, weight, girth, abdominal ultrasound, forearm blood flow, plasma renin activity, angiotensin, and aldosterone, repeated during a 6 month period.


Criteria:

Inclusion Criteria: - Cirrhosis of any etiology - Age 18-80 years - Moderate to severe ascites Exclusion Criteria: - No or small ascites - Severe hepatic hydrothorax - Recent GI (gastrointestinal) hemorrhage - Active bacterial infection - Cardiac failure - Organic renal disease - Hepatocellular carcinoma - Severe comorbidity (advanced neoplasia)


NCT ID:

NCT00108355


Primary Contact:

Principal Investigator
Guadalupe Garcia-Tsao, MD
VA Connecticut Health Care System (West Haven)


Backup Contact:

N/A


Location Contact:

West Haven, Connecticut 06516
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: December 15, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.